Amylyx Pharmaceuticals Announces Launch Of Public Offering Of 6M Shares Of Common Stock
Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the launch of an underwritten public offering of 6,000,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S.
Playtika Reveals Preliminary Results Of Oversubscribed Tender Offer
Mobile gaming entertainment and technology company Playtika Holding Corp (NASDAQ:PLTK) announced the preliminary results of its August 29 tender offer to purchase…
Zealand Pharma Announces Directed Issue And Private Placement Of ~4.5M New Shares
Company announcement – No. 43 / 2022
Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE
XORTX Announces $5M Public Offering
XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat
Rocket Pharmaceuticals Priced 6.*M Share Public Offering of Common Stock @ $14.75/Share
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 6,800,000 shares of its common stock at a public offering price of $14.75 per share.
Rocket Pharmaceuticals Announces Proposed Public Offering Of $100M Of Shares Of Its Common Stock
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of investigational genetic therapies for rare childhood disorders with high